The Enterprise Value as of December 2024 (TTM) for Alterity Therapeutics Limited (PRNAF) is 19.44M

According to Alterity Therapeutics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 19.44M. This represents a change of 219.51% compared to the average of 6.08M of the last 4 quarters.

Alterity Therapeutics Limited (PRNAF) Historical Enterprise Value (quarterly & annually)

How has PRNAF Enterprise Value performed in the past?

The mean historical Enterprise Value of Alterity Therapeutics Limited over the last ten years is 11.22M. The current 19.44M Enterprise Value has changed 17.23% with respect to the historical average. Over the past ten years (40 quarters), PRNAF's Enterprise Value was at its highest in in the September 2014 quarter at 85.84M. The Enterprise Value was at its lowest in in the December 2016 quarter at -3782569.52.

Alterity Therapeutics Limited (PRNAF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Alterity Therapeutics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alterity Therapeutics Limited (PRNAF) Average Enterprise Value

How has PRNAF Enterprise Value performed in the past?

The current Enterprise Value of Alterity Therapeutics Limited (PRNAF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Alterity Therapeutics Limited (PRNAF) Enterprise Value vs. Peers

How is PRNAF’s Enterprise Value compared to its peers?

Alterity Therapeutics Limited’s Enterprise Value is greater than Genprex, Inc. (6.03M), less than Reviva Pharmaceuticals Holdings, Inc. (79.76M), less than Greenwich LifeSciences, Inc. (152.23M), greater than Cognition Therapeutics, Inc. (6.95M), less than Gracell Biotechnologies Inc. (5.66B), less than Galectin Therapeutics Inc. (0), less than Northwest Biotherapeutics, Inc. (135.47M), less than CEL-SCI Corporation (408.30M), less than Tonix Pharmaceuticals Holding Corp. (56.57M), less than Jaguar Health, Inc. (47.71M), less than Acasti Pharma Inc. (33.14M), greater than Diffusion Pharmaceuticals Inc. (14.78M), greater than iBio, Inc. (10.95M), greater than Vaxart, Inc. (15.34M), less than Novavax, Inc. (137.25M), less than Ocugen, Inc. (1.00B), less than CohBar, Inc. (185.97M), greater than Rain Therapeutics Inc. (-4331919.00), greater than Viking Therapeutics, Inc. (7.16M), less than TG Therapeutics, Inc. (4.77B), less than X4 Pharmaceuticals, Inc. (5.14B), less than PDS Biotechnology Corporation (107.00M), less than Madrigal Pharmaceuticals, Inc. (37.39M), less than null (6.70B),

Build a custom stock screener for Alterity Therapeutics Limited (PRNAF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alterity Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alterity Therapeutics Limited (PRNAF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alterity Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.